Video

Exercise and Lifestyle Factors in Patients with mCRC

For High-Definition, Click

Lifestyle choices have a significant impact on outcomes for patients with metastatic colorectal cancer (CRC). Health improvement, including exercise and proper nutrition, is an important part of the patient-physician discussion. The magnitude of impact on long-term outcomes associated with exercise and nutrition is similar to what can be seen with chemotherapy, suggests Herbert I. Hurwitz, MD.

Physicians should discuss healthy lifestyle choices with every patient who completes adjuvant therapy, Axel Grothey, MD, explains. This should place particular emphasis on increasing exercise, normalizing body weight, lowering alcohol consumption, and eating less red meat. Additionally, data are emerging on the use of aspirin and vitamin D, which should be incorporate into the conversation.

The benefits of a health lifestyle are important during treatment, not just in the adjuvant setting, Alan Venook, MD, notes. According to research by Meyerhardt and Fuchs, lifestyle factors matter during the course of the adjuvant therapy, as well as afterward. The optimal time to have a conversation about a healthy lifestyle is during the initiation of therapy, as the benefits associated with this intervention are very compelling, suggests Daniel Haller, MD.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Related Videos
Katherine L. Nathanson, MD
Dr Garrido-Laguna on the Safety of Daraxonrasib in KRAS G12X–Mutated PDAC
Aditya Bardia, MD, MPH, FASCO
Dr Fakih on the FDA Approval of Sotorasib Plus Panitumumab for KRAS G12C–Mutated mCRC
Jin-Ji Yang, MD, of Guangdong Lung Cancer Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University
Kanwal P.S. Raghav, MBBS, MD
Richard T. Lee, MD, Cherng Family Director’s Chair, Center for Integrative Oncology, medical director, clinical professor, Supportive & Integrative Medicine, Department of Supportive Care Medicine, City of Hope
Rachna T. Shroff, MD, MS
E. Gabriela Chiorean, MD, FASCO, clinical director, GI Medical Oncology Program, professor, Clinical Research Division, and affiliate investigator, Translational Science and Therapeutics Division Fred Hutchinson Cancer Center; professor, medicine, University of Washington; director, Clinical Research GI Oncology Program, University of Washington/Fred Hutch
Daneng Li, MD, associate professor, Department of Medical Oncology & Therapeutics Research, and co-director, Neuroendocrine Tumor Program, City of Hope